← Open Payments lookup

MELISSA GIMENEZ: Open Payments

NPI 1447880745 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,147 in 160 payments from 16 companies in 2025. Trend: 2023 $290 · 2024 $1,637 · 2025 $3,147

Food & beverage: $3,118Education: $29
CompanyPaymentsAmount
ABBVIE INC.39$612
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$400
Otsuka America Pharmaceutical, Inc.18$380
Axsome Therapeutics, Inc.14$323
Vanda Pharmaceuticals Inc.17$286
Neurocrine BioSciences, Inc.9$231
Teva Pharmaceuticals USA, Inc.9$222
Janssen Pharmaceuticals, Inc6$178
Alkermes, Inc.8$150
Lundbeck LLC4$116

Products named: VRAYLAR, CAPLYTA, REXULTI, Auvelity, FANAPT, INGREZZA, AUSTEDO XR, ARISTADA.

Industry payments across TX — which companies pay providers there.